CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...

The system that has driven life-altering discoveries and helped make the United States a superpower is now under intense ...

When the beloved science publication got too political, its corporate owners stepped in. Now its future is uncertain. In ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Through the Young Researchers Institute Fellowship, students are learning how AI can expand access to scientific research, ...

Eurofins Scientific updated its 2026 guidance after weaker than usual market conditions and cancelled clinical programmes, ...

EVERSANA has acquired Estima Scientific, a London-based health economics and outcomes research technology and services ...

Boston Scientific (BSX) stock falls as the company, with its Q3 2026 results, cuts its outlook, citing impact from a recent ...

Omabit, a company developing AI to support scientific decision-making, today announced $2 million in seed financing led by Bright Ventures. Omabit integrates a life science company’s own genomic, ...

Fintel reports that on October 29, 2026, Jefferies downgraded their outlook for Boston Scientific (BMV:BSX) from Buy to Hold.

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

Before this year, two heart-device product lines from Boston Scientific were booming and made the company a star of the ...